Festival of Books
Everything you need to know about the Festival of Books


U.S. Supreme Court
Why the execution drug shortage won't go away
Why the execution drug shortage won't go away

In a few weeks, the U.S. Supreme Court will hear Glossip vs. Gross, which examines the use of the drug midazolam in lethal injection executions. The case comes on the heels of an infamously gruesome 2014, a year that saw botched executions in Ohio, Oklahoma and Arizona. The states' problems stem from their increasing difficulty obtaining effective, reliable, FDA-approved drugs to use in lethal injections. The reason is simple: Drug companies don't want their products used to kill people. But that's not what we're told by state officials. They claim the shortage is strictly the result of anti-death penalty activists harassing the drug companies into abandoning the...